Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update (GlobeNewswire) - Jan 4, 2024 - "IND-enabling toxicology studies of THB335 nearing completion; Pre-IND interaction with the U.S. FDA now complete; Program remains on track to file a U.S. IND and initiate a Phase 1 study of THB335 during the first half of 2024."
FDA event • IND • New P1 trial • Chronic Spontaneous Urticaria • Dermatology • Urticaria
|